These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36656233)

  • 21. Naproxen-associated sudden sensorineural hearing loss.
    McKinnon BJ; Lassen LF
    Mil Med; 1998 Nov; 163(11):792-3. PubMed ID: 9819544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naproxen-induced anemia and hypoalbuminemia in a 16-month-old child.
    Boodhan S; Friedman JN
    Clin Pediatr (Phila); 2009 Jan; 48(1):96-8. PubMed ID: 18632553
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
    Obeid S; Libby P; Husni E; Wang Q; Wisniewski LM; Davey DA; Wolski KE; Xia F; Bao W; Walker C; Ruschitzka F; Nissen SE; Lüscher TF
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(6):611-621. PubMed ID: 35234840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I; Szer IS; Zemel LS; Lovell DJ; Giannini EH; Robbins JL; West CR; Steidle G; Krishnaswami S; Bloom BJ
    J Rheumatol; 2009 Jan; 36(1):174-82. PubMed ID: 19012356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naproxen in the treatment of juvenile rheumatoid arthritis. Metabolism, safety and efficacy.
    Mäkelä AL
    Scand J Rheumatol; 1977; 6(4):193-205. PubMed ID: 343231
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drugs in pediatric patients.
    Stiehm ER
    Am J Dis Child; 1988 Dec; 142(12):1281-2. PubMed ID: 3195526
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
    Sobel RE; Lovell DJ; Brunner HI; Weiss JE; Morris PW; Gottlieb BS; Chalom EC; Jung LK; Onel KB; Petiniot L; Goldsmith DP; Nanda K; Shishov M; Abramsky S; Young JP; Giannini EH;
    Pediatr Rheumatol Online J; 2014; 12():29. PubMed ID: 25057265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.
    Piñana E; Lei SH; Merino R; Melgosa M; De La Vega R; Gonzales-Obeso E; Ramírez E; Borobia A; Carcas A
    J Clin Pharm Ther; 2010 Jun; 35(3):365-70. PubMed ID: 20831538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.
    Wallace CA; Smith AL; Sherry DD
    J Rheumatol; 1993 Oct; 20(10):1764-8. PubMed ID: 8295192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
    Caldwell JR; Roth SH
    J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
    Angiolillo DJ; Datto C; Raines S; Yeomans ND
    J Thromb Thrombolysis; 2014 Jul; 38(1):11-23. PubMed ID: 24368727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease.
    Laxer RM; Silverman ED; Balfe JW; Poucell S; Baumal R
    Pediatrics; 1987 Dec; 80(6):904-8. PubMed ID: 3684403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
    Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
    J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Oct; 18(4):241-77. PubMed ID: 387372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    Nissen SE; Yeomans ND; Solomon DH; Lüscher TF; Libby P; Husni ME; Graham DY; Borer JS; Wisniewski LM; Wolski KE; Wang Q; Menon V; Ruschitzka F; Gaffney M; Beckerman B; Berger MF; Bao W; Lincoff AM;
    N Engl J Med; 2016 Dec; 375(26):2519-29. PubMed ID: 27959716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
    Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
    Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leukocytoclastic vasculitis associated with naproxen].
    Lossos IS; Yossepowitch O; Amir G; Orren R
    Harefuah; 1996 May; 130(9):600-1, 655. PubMed ID: 8794637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis.
    Laine L; Bombardier C; Hawkey CJ; Davis B; Shapiro D; Brett C; Reicin A
    Gastroenterology; 2002 Oct; 123(4):1006-12. PubMed ID: 12360461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.